缅北禁地

I am a consultant nephrologist at 缅北禁地 upon Tyne Hospitals NHS Foundation Trust and associate clinical lecturer at the Institute of Cellular Medicine. My clinical time is divided between the and .

My main clinical role is providing expert advice for the diagnosis and management of atypical haemolytic uraemic syndrome (aHUS) and C3 glomerulopathy (C3G) nationally. This includes implementing the NHS England Highly Specialised Services policies on the use of eculizumab in the treatment of these conditions. (/ ) 

Leadership Roles: Clinical lead for C3G within the National Renal Complement Therapeutic Centre / Member of the MPGN/C3G Rare Disease Group

I undertook my speciality training in renal medicine in the North East (2008-2017), during which I completed an extensive period of research in complement-mediated renal diseases as a MRC Clinical Research Training Fellow (2013-2016) and NIHR Academic Clinical Lecturer (2016-2017).

In my research period, I studied complement abnormalities in aHUS, C3G and membranoproliferative glomerulonephritis (MPGN), through laboratory and clinical research methods.

I have published my work in top-ranking nephrology journals (J Am Soc Nephol / Kidney Int) and presented my work in national and international meetings.

I was awarded a for my PhD in 2016 and the prestigious Renal Association (Young Investigator)  in 2017. 

• Wong EKS, Kavanagh D. . Seminars in Immunopathology 2018, 40(1), 49-64.
• Farmery JHR, Smith ML, NIHR BioResource - Rare Diseases, (group includes, Chinnery P, Corris PA, Emmerson I, Horvath R, Johnson S, Shipley D, Wong EKS), Lynch AG. . Scientific Reports 2018, 8, 1300.
• Kerr H, Wong E, Makou E, Yang Y, Marchbank K, Kavanagh D, Richards A, Herbert A, Barlow P. . Journal of Biological Chemistry 2017, 292, 13345-13360.
• Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh P, Wong EKS, Booth C, Kerecuk L, Salama A, Almond M, Inward C, Goodship TH, Sheerin N, Marchbank KJ, Kavanagh D. . Kidney International 2017, 92(5), Pages 1261-1271.
• Bruel A, Kavanagh D, Noris M, Delmas Y, Wong E, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F. . Clinical Journal of the American Society of Nephrology 2017, 12(8), 1237-1247.
• Challis RC, Araujo GSR, Wong EKS, Anderson HE, Awan A, Dorman AM, Waldron M, Wilson V, Brocklebank V, Strain L, Morgan BP, Harris CL, Marchbank KJ, Goodship THJ, Kavanagh D. . Journal of the American Society of Nephrology 2016, 27(6), 1617-1624.
• Wong EKS, Kavanagh D. . Translational Research 2015, 165(2), 306-320.
• Nichols EM, Barbour TD, Kerr H, Pappworth IY, Wong EKS, Palmer J, Sheerin NS, Herbert A, Barlow PN, Pickering MC, Marchbank KJ. . In: 15th European Meeting on Complement in Human Disease 2015. 2015, Uppsala, Sweden: Elsevier.
• Wong E, Challis R, Sheerin N, Johnson S, Kavanagh D, Goodship TH. . Immunobiology 2015.
• Wong EKS, Marchbank K, Pappworth I, Walters R, Lomax-Browne H, Harris C, Morgan P, Pickering M, Goodship THJ, Malcomson R, Cook T, Johnson S, MPGN C3G Rare Dis Grp. . In: 52nd ERA-EDTA Congress. 2015, London, UK: Oxford University Press.
• Brocklebank V, Wong EKS, Fielding R, Goodship THJ, Kavanagh D. . Clinical Kidney Journal 2014, 7(3), 286-288.
• Wong EKS, Husain A, Sayer JA. . Oxford Medical Case Reports 2014, 2014(5), 86-88.
• Yu Y, Triebwasser MP, Wong EKS, Schramm EC, Thomas B, Reynolds R, Mardis ER, Atkinson JP, Daly M, Raychaudhuri S, Kavanagh D, Seddon JM. . Human Molecular Genetics 2014, 23(19), 5283-5293.
• Wong EKS, Goodship THJ, Kavanagh D. . Molecular Immunology 2013, 56(3), 199-212.